Submission Details
| 510(k) Number | K242667 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 05, 2024 |
| Decision Date | January 15, 2025 |
| Days to Decision | 132 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K242667 is an FDA 510(k) clearance for the AeroChamber2go Anti-Static Valved Holding Chamber, a Holding Chambers, Direct Patient Interface (Class II — Special Controls, product code NVP), submitted by Trudell Medical International (London, CA). The FDA issued a Cleared decision on January 15, 2025, 132 days after receiving the submission on September 5, 2024. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5630.
| 510(k) Number | K242667 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 05, 2024 |
| Decision Date | January 15, 2025 |
| Days to Decision | 132 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | NVP — Holding Chambers, Direct Patient Interface |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5630 |
| Definition | Holding Chambers Are Devices That Are Used With Nebulizers And Metered Dose Inhalers And Are Comprised Of A Reservoir Into Which An Aerosol Medication Is Dispensed. A Holding Chamber Uses A Valved Mouthpiece Through Which The Patient Inhales The Dispensed Medication. Holding Chambers Are Intended To Minimize Delivery Of Large Aerosolized Particles |